当前位置:首页 - 行情中心 - 广济药业(000952) - 财务分析 - 现金流量表

广济药业

(000952)

  

流通市值:25.32亿  总市值:25.52亿
流通股本:3.44亿   总股本:3.47亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金189,602,012.29625,750,089.99469,573,025.71303,361,830.08
  收到的税费返还1,894,305.0818,328,274.5117,569,623.0716,850,632.05
  收到其他与经营活动有关的现金3,293,891.8422,833,757.3216,937,174.317,258,553.17
  经营活动现金流入小计194,790,209.21666,912,121.82504,079,823.09327,471,015.3
  购买商品、接受劳务支付的现金109,518,211.1368,682,133.41273,002,990.07174,916,815.1
  支付给职工以及为职工支付的现金29,676,947.78127,488,327.88100,547,667.9270,565,852.62
  支付的各项税费7,958,421.8229,952,433.9920,082,458.1514,272,779.11
  支付其他与经营活动有关的现金14,863,202.5380,361,248.4562,803,799.8842,452,967.34
  经营活动现金流出小计162,016,783.23606,484,143.73456,436,916.02302,208,414.17
  经营活动产生的现金流量净额32,773,425.9860,427,978.0947,642,907.0725,262,601.13
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额1,000,0004,998,030--
  处置子公司及其他营业单位收到的现金净额-55,437,259.455,437,259.444,786,222.02
  投资活动现金流入小计1,000,00060,435,289.455,437,259.444,786,222.02
  购建固定资产、无形资产和其他长期资产支付的现金2,696,249.1535,640,557.3332,342,774.5423,676,518.81
  投资活动现金流出小计2,696,249.1535,640,557.3332,342,774.5423,676,518.81
  投资活动产生的现金流量净额-1,696,249.1524,794,732.0723,094,484.8621,109,703.21
三、筹资活动产生的现金流量:
  取得借款收到的现金386,295,813.8742,684,602.95558,338,210.76486,661,000
  收到其他与筹资活动有关的现金---250,000,000
  筹资活动现金流入小计386,295,813.8742,684,602.95558,338,210.76736,661,000
  偿还债务支付的现金357,864,751.76794,815,725.64622,756,521.74531,444,065.85
  分配股利、利润或偿付利息支付的现金10,610,925.4750,946,079.4538,436,982.8227,211,085.96
  支付其他与筹资活动有关的现金336,86422,348,86922,880,354.7222,348,869
  筹资活动现金流出小计368,812,541.23868,110,674.09684,073,859.28581,004,020.81
  筹资活动产生的现金流量净额17,483,272.57-125,426,071.14-125,735,648.52155,656,979.19
四、汇率变动对现金及现金等价物的影响-812,194.26784,310.61827,636.971,200,572.93
五、现金及现金等价物净增加额47,748,255.14-39,419,050.37-54,170,619.62203,229,856.46
  加:期初现金及现金等价物余额267,758,214.81307,177,265.18307,177,265.18307,177,265.18
  期末现金及现金等价物余额315,506,469.95267,758,214.81253,006,645.56510,407,121.64
补充资料:
  净利润--438,947,124.55--82,303,764.28
  资产减值准备-299,848,489.13-2,058,122.98
  固定资产和投资性房地产折旧-153,470,396.13-77,224,568.28
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-153,470,396.13-77,224,568.28
  无形资产摊销-6,183,592.65-3,183,536.08
  长期待摊费用摊销-1,792,091.13-930,919.4
  处置固定资产、无形资产和其他长期资产的损失--549,256.12--
  固定资产报废损失-206,983.94--
  财务费用-51,155,779.37-26,434,422.46
  投资损失--18,384,643.69--
  递延所得税--4,187,763.87-554,342.67
  其中:递延所得税资产减少--4,046,754.67-617,056.75
    递延所得税负债增加--141,009.2--62,714.08
  存货的减少-47,794,118.85--35,562,029.33
  经营性应收项目的减少--118,473,819.77--70,643,992.61
  经营性应付项目的增加-90,632,735.71-112,570,932.59
  其他--10,745,876.98--9,522,282.92
  现金的期末余额-267,758,214.81-510,407,121.64
  减:现金的期初余额-307,177,265.18-307,177,265.18
  现金及现金等价物的净增加额--39,419,050.37-203,229,856.46
公告日期2026-04-252026-04-252025-10-272025-08-29
审计意见(境内)标准无保留意见
TOP↑